| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 3.92e-04 | 21 | 28 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 6.21e-04 | 120 | 28 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 1.16e-03 | 36 | 28 | 2 | GO:0031624 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 1.58e-03 | 42 | 28 | 2 | GO:0044390 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.26e-03 | 188 | 28 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 2.70e-03 | 200 | 28 | 3 | GO:0008237 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.88e-03 | 430 | 28 | 4 | GO:0004175 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.51e-03 | 749 | 28 | 5 | GO:0005509 | |
| GeneOntologyCellularComponent | PR-DUB complex | 1.11e-05 | 4 | 29 | 2 | GO:0035517 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.48e-05 | 656 | 29 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.53e-05 | 658 | 29 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.46e-05 | 530 | 29 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | microfibril | 1.44e-04 | 13 | 29 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | PcG protein complex | 2.36e-03 | 52 | 29 | 2 | GO:0031519 | |
| Domain | cEGF | 3.34e-10 | 26 | 28 | 5 | IPR026823 | |
| Domain | cEGF | 3.34e-10 | 26 | 28 | 5 | PF12662 | |
| Domain | EGF_1 | 2.66e-09 | 255 | 28 | 8 | PS00022 | |
| Domain | EGF-like_CS | 3.19e-09 | 261 | 28 | 8 | IPR013032 | |
| Domain | EGF_2 | 3.59e-09 | 265 | 28 | 8 | PS01186 | |
| Domain | EGF_3 | 4.32e-08 | 235 | 28 | 7 | PS50026 | |
| Domain | EGF-like_dom | 6.42e-08 | 249 | 28 | 7 | IPR000742 | |
| Domain | Growth_fac_rcpt_ | 9.98e-08 | 156 | 28 | 6 | IPR009030 | |
| Domain | EGF_CA | 1.66e-07 | 86 | 28 | 5 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 3.04e-07 | 97 | 28 | 5 | IPR018097 | |
| Domain | EGF_CA | 3.37e-07 | 99 | 28 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.55e-07 | 100 | 28 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.74e-07 | 106 | 28 | 5 | IPR000152 | |
| Domain | EGF_CA | 9.54e-07 | 122 | 28 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.03e-06 | 124 | 28 | 5 | IPR001881 | |
| Domain | EGF | 1.11e-06 | 235 | 28 | 6 | SM00181 | |
| Domain | HARE-HTH | 6.50e-06 | 3 | 28 | 2 | PF05066 | |
| Domain | ASXH | 6.50e-06 | 3 | 28 | 2 | PF13919 | |
| Domain | PHD_3 | 6.50e-06 | 3 | 28 | 2 | PF13922 | |
| Domain | HB1/Asxl_HTH | 6.50e-06 | 3 | 28 | 2 | IPR007759 | |
| Domain | ASX-like_PHD | 6.50e-06 | 3 | 28 | 2 | IPR026905 | |
| Domain | ASX/ASX-like | 6.50e-06 | 3 | 28 | 2 | IPR024811 | |
| Domain | FBN | 6.50e-06 | 3 | 28 | 2 | IPR011398 | |
| Domain | ASXH | 6.50e-06 | 3 | 28 | 2 | IPR028020 | |
| Domain | ADAM_Cys-rich | 8.62e-06 | 27 | 28 | 3 | IPR006586 | |
| Domain | ACR | 8.62e-06 | 27 | 28 | 3 | SM00608 | |
| Domain | Peptidase_M12B_N | 2.66e-05 | 39 | 28 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.66e-05 | 39 | 28 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 2.87e-05 | 40 | 28 | 3 | PS00427 | |
| Domain | ADAM_MEPRO | 2.87e-05 | 40 | 28 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.87e-05 | 40 | 28 | 3 | PS50214 | |
| Domain | Reprolysin | 2.87e-05 | 40 | 28 | 3 | PF01421 | |
| Domain | Peptidase_M12B | 2.87e-05 | 40 | 28 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 3.10e-05 | 41 | 28 | 3 | IPR001762 | |
| Domain | EGF | 3.57e-05 | 126 | 28 | 4 | PF00008 | |
| Domain | TB | 4.53e-05 | 7 | 28 | 2 | PF00683 | |
| Domain | - | 6.03e-05 | 8 | 28 | 2 | 3.90.290.10 | |
| Domain | TB | 7.75e-05 | 9 | 28 | 2 | PS51364 | |
| Domain | TB_dom | 7.75e-05 | 9 | 28 | 2 | IPR017878 | |
| Domain | E3_UB_ligase_RBR | 9.68e-05 | 10 | 28 | 2 | IPR031127 | |
| Domain | TSP_1 | 1.13e-04 | 63 | 28 | 3 | PF00090 | |
| Domain | Ephrin_rec_like | 1.18e-04 | 11 | 28 | 2 | PF07699 | |
| Domain | TSP1 | 1.24e-04 | 65 | 28 | 3 | SM00209 | |
| Domain | TSP1_rpt | 1.24e-04 | 65 | 28 | 3 | IPR000884 | |
| Domain | TSP1 | 1.24e-04 | 65 | 28 | 3 | PS50092 | |
| Domain | EGF_3 | 1.42e-04 | 12 | 28 | 2 | PF12947 | |
| Domain | EGF_dom | 1.42e-04 | 12 | 28 | 2 | IPR024731 | |
| Domain | IBR | 1.95e-04 | 14 | 28 | 2 | PF01485 | |
| Domain | IBR | 1.95e-04 | 14 | 28 | 2 | SM00647 | |
| Domain | IBR_dom | 2.25e-04 | 15 | 28 | 2 | IPR002867 | |
| Domain | MetalloPept_cat_dom | 2.38e-04 | 81 | 28 | 3 | IPR024079 | |
| Domain | - | 2.38e-04 | 81 | 28 | 3 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 4.17e-04 | 98 | 28 | 3 | PS00142 | |
| Domain | Kazal_1 | 4.91e-04 | 22 | 28 | 2 | PF00050 | |
| Domain | ADAM_spacer1 | 5.38e-04 | 23 | 28 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 5.38e-04 | 23 | 28 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 5.86e-04 | 24 | 28 | 2 | IPR013273 | |
| Domain | Ephrin_rec_like | 6.36e-04 | 25 | 28 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 6.36e-04 | 25 | 28 | 2 | IPR011641 | |
| Domain | hEGF | 8.00e-04 | 28 | 28 | 2 | PF12661 | |
| Domain | Kazal_2 | 1.32e-03 | 36 | 28 | 2 | PF07648 | |
| Domain | CYSTEINE_SWITCH | 1.71e-03 | 41 | 28 | 2 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 1.88e-03 | 43 | 28 | 2 | IPR001818 | |
| Domain | KAZAL | 2.15e-03 | 46 | 28 | 2 | SM00280 | |
| Domain | CUB | 2.44e-03 | 49 | 28 | 2 | PF00431 | |
| Domain | KAZAL_2 | 2.54e-03 | 50 | 28 | 2 | PS51465 | |
| Domain | CUB | 2.54e-03 | 50 | 28 | 2 | SM00042 | |
| Domain | Kazal_dom | 2.64e-03 | 51 | 28 | 2 | IPR002350 | |
| Domain | - | 2.74e-03 | 52 | 28 | 2 | 2.60.120.290 | |
| Domain | CUB | 2.85e-03 | 53 | 28 | 2 | PS01180 | |
| Domain | CUB_dom | 3.29e-03 | 57 | 28 | 2 | IPR000859 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.09e-06 | 140 | 27 | 5 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.79e-05 | 300 | 27 | 6 | M610 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.17e-05 | 114 | 27 | 4 | MM14571 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.15e-04 | 258 | 27 | 5 | MM14572 | |
| Pathway | REACTOME_MET_RECEPTOR_RECYCLING | 1.57e-04 | 10 | 27 | 2 | M27777 | |
| Pathway | REACTOME_MET_RECEPTOR_RECYCLING | 1.57e-04 | 10 | 27 | 2 | MM15516 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 36068610 | ||
| Pubmed | HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors. | 6.71e-07 | 2 | 29 | 2 | 23045285 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 17947472 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 15234972 | ||
| Pubmed | Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. | 6.71e-07 | 2 | 29 | 2 | 18234969 | |
| Pubmed | ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia. | 6.71e-07 | 2 | 29 | 2 | 28516957 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 28238185 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 22435662 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 22936342 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 23603262 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 31104010 | ||
| Pubmed | Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells. | 2.01e-06 | 3 | 29 | 2 | 23359207 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 21047783 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 21423210 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 31991528 | ||
| Pubmed | Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. | 2.01e-06 | 3 | 29 | 2 | 12270931 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 16412590 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 25835095 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 28063196 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 29284740 | ||
| Pubmed | Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase. | 2.01e-06 | 3 | 29 | 2 | 33731362 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 33751773 | ||
| Pubmed | RNF144A sustains EGFR signaling to promote EGF-dependent cell proliferation. | 4.02e-06 | 4 | 29 | 2 | 30171075 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 4.02e-06 | 4 | 29 | 2 | 25034023 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 34170818 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 19817696 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 19469909 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 20061986 | ||
| Pubmed | Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding. | 4.02e-06 | 4 | 29 | 2 | 34536441 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 20150826 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 26381405 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 23383134 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 19713535 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 29358589 | ||
| Pubmed | Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma. | 1.00e-05 | 6 | 29 | 2 | 19288010 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 19692652 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 25639508 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 10431818 | ||
| Pubmed | Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway. | 1.87e-05 | 8 | 29 | 2 | 31201465 | |
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 26416890 | ||
| Pubmed | Additional sex combs-like family genes are required for normal cardiovascular development. | 2.41e-05 | 9 | 29 | 2 | 24860998 | |
| Pubmed | ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer. | 3.01e-05 | 10 | 29 | 2 | 32669118 | |
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 15314156 | ||
| Pubmed | The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. | 3.01e-05 | 10 | 29 | 2 | 19815555 | |
| Pubmed | 3.38e-05 | 75 | 29 | 3 | 20637190 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 4.41e-05 | 12 | 29 | 2 | 25770910 | |
| Pubmed | Loss of the tumor suppressor BAP1 causes myeloid transformation. | 5.21e-05 | 13 | 29 | 2 | 22878500 | |
| Pubmed | 6.03e-05 | 91 | 29 | 3 | 20546612 | ||
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 7.45e-05 | 272 | 29 | 4 | 18187620 | |
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 20805357 | ||
| Pubmed | 9.06e-05 | 17 | 29 | 2 | 22183742 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 1.02e-04 | 18 | 29 | 2 | 35503090 | |
| Pubmed | 1.02e-04 | 18 | 29 | 2 | 33308444 | ||
| Pubmed | 1.18e-04 | 591 | 29 | 5 | 15231748 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 1.26e-04 | 20 | 29 | 2 | 29785026 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 1.54e-04 | 1005 | 29 | 6 | 19615732 | |
| Pubmed | Large-scale phage-based screening reveals extensive pan-viral mimicry of host short linear motifs. | 1.83e-04 | 24 | 29 | 2 | 37100772 | |
| Pubmed | Many sequence variants affecting diversity of adult human height. | 2.30e-04 | 143 | 29 | 3 | 18391951 | |
| Pubmed | Deletion of Pdcd5 in mice led to the deficiency of placenta development and embryonic lethality. | 2.33e-04 | 27 | 29 | 2 | 28542142 | |
| Pubmed | 2.41e-04 | 689 | 29 | 5 | 36543142 | ||
| Pubmed | 3.62e-04 | 167 | 29 | 3 | 22159717 | ||
| Pubmed | 3.70e-04 | 34 | 29 | 2 | 26411367 | ||
| Pubmed | β-Catenin gain of function in muscles impairs neuromuscular junction formation. | 3.70e-04 | 34 | 29 | 2 | 22627288 | |
| Pubmed | 3.93e-04 | 35 | 29 | 2 | 23376422 | ||
| Pubmed | 3.93e-04 | 35 | 29 | 2 | 34108685 | ||
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 4.16e-04 | 36 | 29 | 2 | 25615642 | |
| Pubmed | 4.16e-04 | 36 | 29 | 2 | 35167946 | ||
| Pubmed | 4.39e-04 | 37 | 29 | 2 | 19266077 | ||
| Pubmed | 5.04e-04 | 449 | 29 | 4 | 31732153 | ||
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 5.95e-04 | 198 | 29 | 3 | 20881960 | |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 7.26e-04 | 212 | 29 | 3 | 33462405 | |
| Pubmed | 8.02e-04 | 50 | 29 | 2 | 23658023 | ||
| Interaction | HSPA14 interactions | 9.24e-06 | 93 | 29 | 4 | int:HSPA14 | |
| Interaction | DPH6 interactions | 1.17e-05 | 31 | 29 | 3 | int:DPH6 | |
| Interaction | DKK1 interactions | 1.29e-05 | 32 | 29 | 3 | int:DKK1 | |
| Interaction | SCUBE1 interactions | 1.99e-05 | 5 | 29 | 2 | int:SCUBE1 | |
| Interaction | SCUBE3 interactions | 5.57e-05 | 8 | 29 | 2 | int:SCUBE3 | |
| Cytoband | 6p21.3 | 1.09e-02 | 250 | 29 | 2 | 6p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 1.61e-02 | 307 | 29 | 2 | chr17q25 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.58e-04 | 19 | 18 | 2 | 50 | |
| GeneFamily | Ring finger proteins | 3.00e-02 | 275 | 18 | 2 | 58 | |
| Coexpression | NABA_MATRISOME | ADAMTS17 SCUBE3 HGF LAMB4 SCUBE1 ADAM19 FBN2 HMCN1 ADAMTS4 WNT1 FBN3 | 5.67e-09 | 1026 | 29 | 11 | M5889 |
| Coexpression | NABA_MATRISOME | 8.88e-07 | 1008 | 29 | 9 | MM17056 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 1.27e-06 | 174 | 29 | 5 | M45676 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 2.30e-06 | 85 | 29 | 4 | M45761 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.24e-05 | 738 | 29 | 7 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.39e-05 | 751 | 29 | 7 | M5885 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.22e-05 | 196 | 29 | 4 | M3008 | |
| Coexpression | BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER | 1.23e-04 | 15 | 29 | 2 | M18219 | |
| Coexpression | BENPORATH_EED_TARGETS | 1.23e-04 | 1059 | 29 | 7 | M7617 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | ADAMTS17 HGF SCUBE1 ADAM19 FBN2 HMCN1 EGFR RNF19A RNF144A TMEFF2 | 4.12e-08 | 773 | 29 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 5.28e-07 | 768 | 29 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.30e-06 | 310 | 29 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.36e-06 | 311 | 29 | 6 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 7.30e-06 | 356 | 29 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 7.80e-06 | 793 | 29 | 8 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 8.23e-06 | 207 | 29 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 8.29e-06 | 364 | 29 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 1.06e-05 | 827 | 29 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | 1.35e-05 | 855 | 29 | 8 | gudmap_developingKidney_e13.5_podocyte cells_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.82e-05 | 418 | 29 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 2.20e-05 | 122 | 29 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 2.43e-05 | 125 | 29 | 4 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 4.58e-05 | 147 | 29 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 5.42e-05 | 54 | 29 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 6.59e-05 | 777 | 29 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 6.72e-05 | 58 | 29 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 7.17e-05 | 165 | 29 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 7.87e-05 | 1094 | 29 | 8 | ratio_EB_vs_SC_2500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.37e-05 | 336 | 29 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.49e-05 | 337 | 29 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 9.82e-05 | 1466 | 29 | 9 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 1.11e-04 | 357 | 29 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.17e-04 | 361 | 29 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 1.19e-04 | 188 | 29 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.26e-04 | 191 | 29 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 1.58e-04 | 385 | 29 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.73e-04 | 433 | 29 | 5 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_500 | 3.37e-04 | 20 | 29 | 2 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 3.48e-04 | 249 | 29 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.53e-04 | 250 | 29 | 4 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 3.72e-04 | 21 | 29 | 2 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.13e-04 | 107 | 29 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.25e-04 | 108 | 29 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.41e-04 | 265 | 29 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 4.68e-04 | 487 | 29 | 5 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 5.15e-04 | 769 | 29 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 5.66e-04 | 783 | 29 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 5.72e-04 | 284 | 29 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 5.97e-04 | 791 | 29 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_100 | 6.19e-04 | 27 | 29 | 2 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.51e-04 | 125 | 29 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.51e-04 | 125 | 29 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 6.81e-04 | 127 | 29 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 7.29e-04 | 130 | 29 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.03e-04 | 311 | 29 | 4 | gudmap_developingKidney_e13.5_podocyte cells_1000_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | 8.66e-04 | 849 | 29 | 6 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 9.26e-04 | 33 | 29 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500 | 9.83e-04 | 34 | 29 | 2 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 1.02e-03 | 146 | 29 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.02e-03 | 146 | 29 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.11e-03 | 339 | 29 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.17e-03 | 153 | 29 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.24e-03 | 156 | 29 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.30e-03 | 354 | 29 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 1.34e-03 | 615 | 29 | 5 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.38e-03 | 162 | 29 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K5 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 1.48e-03 | 166 | 29 | 3 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.50e-03 | 42 | 29 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 1.54e-03 | 371 | 29 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.56e-03 | 951 | 29 | 6 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.57e-03 | 373 | 29 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_200 | 1.72e-03 | 45 | 29 | 2 | gudmap_developingKidney_e13.5_podocyte cells_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 1.82e-03 | 388 | 29 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 1.87e-03 | 986 | 29 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#1 | 1.87e-03 | 47 | 29 | 2 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K1 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.05e-03 | 401 | 29 | 4 | gudmap_kidney_P1_CapMes_Crym_k1_1000 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 2.14e-03 | 189 | 29 | 3 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_500 | 2.27e-03 | 193 | 29 | 3 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 2.29e-03 | 52 | 29 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k2_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 2.30e-03 | 194 | 29 | 3 | gudmap_kidney_P0_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.34e-03 | 195 | 29 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.34e-03 | 195 | 29 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.37e-03 | 196 | 29 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K2 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 2.37e-03 | 196 | 29 | 3 | gudmap_kidney_P1_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.49e-03 | 423 | 29 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 2.59e-03 | 428 | 29 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 2.62e-03 | 429 | 29 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | 2.68e-03 | 432 | 29 | 4 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-06 | 182 | 29 | 4 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 185 | 29 | 4 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 185 | 29 | 4 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 186 | 29 | 4 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Mild-CD8+_T|Mild / Disease group and Cell class | 7.32e-06 | 194 | 29 | 4 | c3dba9ff0ab98b6a955b32d071ad7e397dcdc6e9 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 140 | 29 | 3 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.42e-04 | 157 | 29 | 3 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 161 | 29 | 3 | f470b662566131dfe69a2fd01186ac8491196396 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 1.71e-04 | 167 | 29 | 3 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 168 | 29 | 3 | d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 169 | 29 | 3 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 169 | 29 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 169 | 29 | 3 | eb3b8e473192c4b8688f2f8da400116dd6fe193d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 170 | 29 | 3 | 25d7c61601057fd64d2634fa898b3e56b9de0bc1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 170 | 29 | 3 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-04 | 173 | 29 | 3 | 79d11f94a8f6a420c18c2fef0da77e9af3204765 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.90e-04 | 173 | 29 | 3 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-04 | 174 | 29 | 3 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 176 | 29 | 3 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 176 | 29 | 3 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 178 | 29 | 3 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-04 | 180 | 29 | 3 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | severe-CD8+_T_naive|severe / disease stage, cell group and cell class | 2.13e-04 | 180 | 29 | 3 | 94fe530367b170777f4051a4034cff06d80dbb83 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-04 | 181 | 29 | 3 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-04 | 181 | 29 | 3 | 154d5e586cab25155c6d06dfe6ae01203b88e0fb | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.17e-04 | 181 | 29 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-04 | 181 | 29 | 3 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | severe-CD8+_T_naive|World / disease stage, cell group and cell class | 2.17e-04 | 181 | 29 | 3 | 69eeeb7f326e230b07495d557f708fbe3312ac0a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 182 | 29 | 3 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 182 | 29 | 3 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 2.27e-04 | 184 | 29 | 3 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.31e-04 | 185 | 29 | 3 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-04 | 185 | 29 | 3 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-04 | 185 | 29 | 3 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.31e-04 | 185 | 29 | 3 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.31e-04 | 185 | 29 | 3 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.35e-04 | 186 | 29 | 3 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 186 | 29 | 3 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-04 | 186 | 29 | 3 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 187 | 29 | 3 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 188 | 29 | 3 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 188 | 29 | 3 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 188 | 29 | 3 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.46e-04 | 189 | 29 | 3 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 189 | 29 | 3 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-04 | 189 | 29 | 3 | c80610395d016acc855cfa451e47ea6cecb0556c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-04 | 190 | 29 | 3 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 190 | 29 | 3 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-04 | 190 | 29 | 3 | 83eb0151226b3f5a7dae994a1a519285f9bf6e82 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-04 | 190 | 29 | 3 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-04 | 191 | 29 | 3 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.54e-04 | 191 | 29 | 3 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-04 | 191 | 29 | 3 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.54e-04 | 191 | 29 | 3 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-04 | 191 | 29 | 3 | c5aaf795dccc94ff0c66d08d5525abe2a5f8b98e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 192 | 29 | 3 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.58e-04 | 192 | 29 | 3 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 192 | 29 | 3 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 192 | 29 | 3 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 2.62e-04 | 193 | 29 | 3 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.62e-04 | 193 | 29 | 3 | 02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.62e-04 | 193 | 29 | 3 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.62e-04 | 193 | 29 | 3 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.66e-04 | 194 | 29 | 3 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 2.66e-04 | 194 | 29 | 3 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.66e-04 | 194 | 29 | 3 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 2.66e-04 | 194 | 29 | 3 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-04 | 195 | 29 | 3 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 2.74e-04 | 196 | 29 | 3 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.78e-04 | 197 | 29 | 3 | 2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.78e-04 | 197 | 29 | 3 | 4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.78e-04 | 197 | 29 | 3 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-04 | 197 | 29 | 3 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-04 | 197 | 29 | 3 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-04 | 197 | 29 | 3 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.78e-04 | 197 | 29 | 3 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-04 | 197 | 29 | 3 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-04 | 197 | 29 | 3 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-04 | 197 | 29 | 3 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.78e-04 | 197 | 29 | 3 | 0f37afad46b94c748a149d9ee681472d7a3e6937 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-04 | 198 | 29 | 3 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-04 | 198 | 29 | 3 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 2.82e-04 | 198 | 29 | 3 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.86e-04 | 199 | 29 | 3 | 70e05d7c0c68c28754ce0e72434b205aed6287ae | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 199 | 29 | 3 | 137ff58897e6ada8a5a70205f66fe9110795506b | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | bfdafb024a7b20d46837b2e6480dd4929253cd62 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 04954fbe1e2264077228bb582c9a5897a70e6da2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.90e-04 | 200 | 29 | 3 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.60e-06 | 3 | 28 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | refractive error | 2.43e-04 | 326 | 28 | 4 | MONDO_0004892 | |
| Disease | Neoplasm Recurrence, Local | 6.30e-04 | 39 | 28 | 2 | C0027643 | |
| Disease | diabetes mellitus (is_marker_for) | 6.96e-04 | 41 | 28 | 2 | DOID:9351 (is_marker_for) | |
| Disease | high grade glioma (is_marker_for) | 7.30e-04 | 42 | 28 | 2 | DOID:3070 (is_marker_for) | |
| Disease | FEV/FEC ratio | 8.79e-04 | 1228 | 28 | 6 | EFO_0004713 | |
| Disease | peak expiratory flow | 1.19e-03 | 498 | 28 | 4 | EFO_0009718 | |
| Disease | diabetic retinopathy (is_marker_for) | 1.21e-03 | 54 | 28 | 2 | DOID:8947 (is_marker_for) | |
| Disease | cortical surface area measurement | 1.41e-03 | 1345 | 28 | 6 | EFO_0010736 | |
| Disease | rheumatoid arthritis (is_marker_for) | 1.96e-03 | 69 | 28 | 2 | DOID:7148 (is_marker_for) | |
| Disease | Colorectal Neoplasms | 2.25e-03 | 277 | 28 | 3 | C0009404 | |
| Disease | age of onset of asthma | 2.56e-03 | 79 | 28 | 2 | OBA_2001001 | |
| Disease | central corneal thickness | 3.07e-03 | 309 | 28 | 3 | EFO_0005213 | |
| Disease | Glioma | 3.09e-03 | 87 | 28 | 2 | C0017638 | |
| Disease | Abnormality of refraction | 3.55e-03 | 673 | 28 | 4 | HP_0000539 | |
| Disease | corpus callosum volume measurement | 4.06e-03 | 100 | 28 | 2 | EFO_0010299 | |
| Disease | Colorectal Carcinoma | 4.13e-03 | 702 | 28 | 4 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FGNCGKDMNGEHRKC | 551 | Q9H013 | |
| KDSCYNMMQCIAAGH | 11 | Q7L8W6 | |
| GGNNCMDMRKSVCFR | 1641 | Q75N90 | |
| KAMIMCQGCGAFCHD | 1511 | Q8IXJ9 | |
| AMIMCKGCGAFCHDD | 1406 | Q76L83 | |
| GMNATFCRNMEHLMC | 481 | Q8TE56 | |
| SSQACRAMEEMHGQC | 76 | Q8IUH3 | |
| PDGKMHGNLCSMCQA | 321 | Q9NQ38 | |
| DGKMHGNKCAMCASV | 521 | Q9NQ38 | |
| FMNQPGTGHCEMCSL | 591 | Q8TAT6 | |
| ACMKNCGRRFHNEVG | 71 | Q9NZ52 | |
| CMTCNGESYRGLMDH | 211 | P14210 | |
| HMACSMACGGRACKY | 51 | A2A3K4 | |
| QFGHMQCNCMMGVFP | 96 | O75694 | |
| EGCAQMMCKNCKHAF | 196 | P50876 | |
| VHCGPNRMCFNMRGS | 5481 | Q96RW7 | |
| MSMDFQNHLGSCQKC | 176 | P00533 | |
| CMGGRCLHMDQLQDF | 501 | O75173 | |
| CFHQGNSQCSRLMMH | 66 | Q4VC39 | |
| FCNGHASECRPMQKM | 266 | A4D0S4 | |
| VNGGHNCMDMRKSFC | 1726 | P35556 | |
| CIHRSNEGMNCMNKD | 156 | Q8IWY4 | |
| NEGMNCMNKDHGCAH | 161 | Q8IWY4 | |
| EEGMNCMNKNHGCAH | 156 | Q8IX30 | |
| MCKGVRNMFHSCTGQ | 231 | O75691 | |
| GFCMHGKCEHSINMQ | 271 | Q9UIK5 | |
| MNDGSCNHMTCAVCG | 311 | Q9NV58 | |
| LCQGCGQFIMHRMLA | 111 | Q6GPH4 | |
| FSEMRQECKCHGMSG | 211 | P04628 | |
| NIMMHEGFGKVFSCQ | 151 | Q96JM2 | |
| VCRHFMMKGNCRYEN | 911 | Q96QC0 |